ReviewPharmaceuticals (Basel, Switzerland)2025

C16-siRNAs in Focus: Development of ALN-APP, a Promising RNAi-Based Therapeutic for Alzheimer's Disease.

Ricardo Titze-de-Almeida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.